3D in vitro modelling using material from the Breast Cancer Now Tissue Bank

Size: px
Start display at page:

Download "3D in vitro modelling using material from the Breast Cancer Now Tissue Bank"

Transcription

1 @QMBCI bartscancerinstitute 3D in vitro modelling using material from the Breast Cancer Now Tissue Bank Richard Grose Barts Cancer Institute Ed Carter

2 Normal Breast Architecture Calponin / CK8 Myoepithelial Cell Cancerous Normal Breast Duct Ductal Carcinoma in-situ Invasive Breast Cancer Normal breast duct consists of a ring of polarised luminal epithelial cells surrounded by myoepithelial cells Myoepithelial cells: Provide polarisation cues to luminal cells Contract during lactation to propel milk through the ductal tree

3 Myoepithelial and s: A Close Relationship Myoepithelial Cell Cancerous Normal Breast Duct Ductal Carcinoma in-situ Invasive Breast Cancer Relationship begins to break down in ductal carcinoma in situ and falls apart in invasive breast cancer Approximately 50% of DCIS cases will progress to invasive breast cancer

4 Myoepithelial Cells may Promote Tumourigenesis Normal Tumour Suppressing z DCIS Tumour Promoting Structural z MMP2 BM Synthesis MMP Activity TIMP-1 z z VEGF CD10 Maspin VEGF z SMA z Understanding relationship will lead to novel prognostic markers and new therapeutic targets Need a model to study this...

5 Primary Breast Epithelial Cells Breast tissue samples can be reduced to their individual cellular components for tissue culture applications Readily accessible through Breast Cancer Now tissue bank Collagenase/ Hyaluronidase Breast Tissue Organoids Trypsin Single MECs Sedimentation CD10 EPCAM Fibroblasts Myoepithelial Luminal Contact details:

6 Modelling the Breast Bilayer Aim - Generate a model of the breast duct bilayer to interrogate myoepithelial / luminal interactions in the progression of breast cancer Breast ducts from reduction mammoplasty Isolation of luminal and myoepithelial cells 2D culture of individual cell populations infection with viral particles Combine cells in 3D matrix and culture analyse by confocal microscopy

7 Myoepithelial and s can be Isolated from Reduction Mammoplasty Specimens Myoepithelial 40% CD10 + APC 40% EpCAM + Luminal PE

8 P63 CK14 Calponin Primary Myoepithelial and s Retain their Characteristics in vitro Myoepithelial Luminal Calponin CK14 P63 CK8 CK19 HSC70 10 days in 2D culture CK19 CK8

9 Myoepithelial and s Coalesce in Collagen Gels to form Spherical and Ductal Structures Collagen Gel Breast Section Day 0 Day 21 Day 3 Myoepithelial / Luminal Day 21 CK8 / P-Cadherin / Nuclei

10 Matrigel Does Not Promote Reformation of Bilayer Myoepithelial / Luminal CK8 P-Cadherin Merge Matrigel promotes bipotency of luminal and myoepithelial cells

11 Modelling DCIS in a Physiologically Reflective Setting Myoepithelial Cell HER2 Expression in s Cancerous Normal Breast Duct Ductal Carcinoma in-situ Invasive Breast Cancer Physiological bilayer can be recreated through recombination of myoepithelial and luminal cells in 3D gels Does HER2 overexpression recapitulate DCIS?

12 Modelling DCIS in a Physiologically Reflective Setting HER2 Virus Dox (µg/ml) HER2 HSC70 D0: Embed Cells D14: Ducts Form -Induce Overexpression D21: Analyse

13 Overexpression of HER2 Destabilises Bilayer Control +DOX +DOX +Trastuzumab HER2

14 Quantifying Luminal Filling Collaboration with James Gopsill, University of Bristol Cell volume / body volume ratio Control ** ** Doxycycline Doxycycline + Trastuzumab

15 Luminal HER2 expression recapitulates DCIS HER2-Expressing Spheroid DCIS Breast Section HER2/Vimentin Doxycycline Myoepithelial Cell HER2 Expression in s Cancerous Normal Breast Duct Ductal Carcinoma in-situ Invasive Breast Cancer

16 ITGB6 αsma DCIS to Invasive Cancer - Integrin α V β 6 Integrin α V β 6 is upregulated in the myoepithelial cells of high grade DCIS breast cancer Expression promotes MMP9 production and matrix remodelling Normal Low Grade DCIS High Grade DCIS Allen, M.D. et al. (2014) Clin. Can. Res. 20(2):344-57

17 Progressing DCIS to Invasive Cancer Myoepithelial Cell HER2 Expression in s β6 Expression in Myoepithelial Cells Cancerous Normal Breast Duct Ductal Carcinoma in-situ Invasive Breast Cancer Luminal HER2 expression recapitulates DCIS Does co-overexpression of ITGB6 in myoepithelial cells push the model to invasive cancer?

18 Progressing DCIS to Invasive Cancer Myoepithelial Cell HER2 Expression in s β6 Expression in Myoepithelial Cells Cancerous Normal Breast Duct Ductal Carcinoma in-situ Invasive Breast Cancer ç ç

19 Luminal / ITGB6 Myoepithelial Luminal / Myoepithelial ITGB6 Induction in Myoepithelial Cells Promotes Invasion Vimentin / Her2 / Nuclei

20 Summary Normal breast cells can be isolated, manipulated and recombined in 3D cultures These models allow us an objective view on cell-cell and cell-matrix interactions in the development of the breast duct and in the progression of breast cancer These insights will allow increased understanding of cell signalling in the breast and help in identifying novel biomarkers of disease progression Meet the expert.. Ed Carter Poster Block 13 Carter, E.P. et al. (2017) Breast Cancer Research. 19(1):50.

21 Acknowledgements Ed Carter Louise Jones Jenny Gomm James Gopsill Lucía Fernández Adrienne Morgan Mike Allen Iain Goulding Linda Haywood John Marshall Breast Cancer Now tissue bank donors

University of Bristol - Explore Bristol Research

University of Bristol - Explore Bristol Research Carter, E. P., Gopsill, J. A., Gomm, J. J., Jones, J. L., & Grose, R. P. (2017). A 3D in vitro model of the human breast duct: A method to unravel myoepithelial-luminal interactions in the progression

More information

1. The metastatic cascade. 3. Pathologic features of metastasis. 4. Therapeutic ramifications. Which malignant cells will metastasize?

1. The metastatic cascade. 3. Pathologic features of metastasis. 4. Therapeutic ramifications. Which malignant cells will metastasize? 1. The metastatic cascade 3. Pathologic features of metastasis 4. Therapeutic ramifications Sir James Paget (1814-1899) British Surgeon/ Pathologist Paget s disease of Paget s disease of the nipple (intraductal

More information

1.The metastatic cascade. 2.Pathologic features of metastasis. 3.Therapeutic ramifications

1.The metastatic cascade. 2.Pathologic features of metastasis. 3.Therapeutic ramifications Metastasis 1.The metastatic cascade 2.Pathologic features of metastasis 3.Therapeutic ramifications Sir James Paget (1814-1899) British Surgeon/ Pathologist Paget s disease of bone Paget s disease of the

More information

Basement membrane in lobule.

Basement membrane in lobule. Bahram Memar, MD Basement membrane in lobule. Normal lobule-luteal phase Normal lobule-follicular phase Lactating breast Greater than 95% are adenocarcinomas in situ carcinomas and invasive carcinomas.

More information

04/10/2018. Intraductal Papillary Neoplasms Of Breast INTRADUCTAL PAPILLOMA

04/10/2018. Intraductal Papillary Neoplasms Of Breast INTRADUCTAL PAPILLOMA Intraductal Papillary Neoplasms Of Breast Savitri Krishnamurthy MD Professor of Pathology Deputy Division Head The University of Texas MD Anderson Cancer Center 25 th Annual Seminar in Pathology Pittsburgh,

More information

Proliferative Epithelial lesions of the Breast. Sami Shousha, MD, FRCPath Charing Cross Hospital & Imperial College, London

Proliferative Epithelial lesions of the Breast. Sami Shousha, MD, FRCPath Charing Cross Hospital & Imperial College, London Proliferative Epithelial lesions of the Breast Sami Shousha, MD, FRCPath Charing Cross Hospital & Imperial College, London Amman, November2013 Proliferative Epithelial Lesions of the Breast Usual type

More information

Papillary Lesions of the Breast

Papillary Lesions of the Breast Papillary Lesions of the Breast Laura C. Collins, M.D. Associate Professor of Pathology Associate Director, Division of Anatomic Pathology Beth Israel Deaconess Medical Center and Harvard Medical School

More information

CLINICAL SIGNIFICANCE OF BENIGN EPITHELIAL CHANGES

CLINICAL SIGNIFICANCE OF BENIGN EPITHELIAL CHANGES Papillomas. Papillomas are composed of multiple branching fibrovascular cores, each having a connective tissue axis lined by luminal and myoepithelial cells ( Fig. 23-11 ). Growth occurs within a dilated

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION DOI: 10.1038/ncb3021 Supplementary figure 1 Characterisation of TIMPless fibroblasts. a) Relative gene expression of TIMPs1-4 by real time quantitative PCR (RT-qPCR) in WT or ΔTimp fibroblasts (mean ±

More information

Keywords Breast tissue Transgender Cell culture Tissue bank Biobank Rare BRIEF COMMUNICATION

Keywords Breast tissue Transgender Cell culture Tissue bank Biobank Rare BRIEF COMMUNICATION Cell Tissue Bank (2015) 16:27 34 DOI 10.1007/s10561-014-9444-y BRIEF COMMUNICATION Adding value to rare tissue samples donated to biobanks: characterisation of breast tissue and primary cell cultures obtained

More information

Benign Mimics of Malignancy in Breast Pathology

Benign Mimics of Malignancy in Breast Pathology Arthur Purdy Stout Society of Surgical Pathologists Companion Meeting Benign Mimics of Malignancy in Breast Pathology Stuart J. Schnitt, M.D. Beth Israel Deaconess Medical Center and Harvard Medical School,

More information

Cancer Biology Course. Invasion and Metastasis

Cancer Biology Course. Invasion and Metastasis Cancer Biology Course Invasion and Metastasis 2016 Lu-Hai Wang NHRI Cancer metastasis Major problem: main reason for killing cancer patients, without it cancer can be cured or controlled. Challenging questions:

More information

Understanding Your Pathology Report

Understanding Your Pathology Report Understanding Your Pathology Report Because every person s breast cancer is unique, it s important to understand the underlying biology of your tumor to personalize your treatment plan. Your physicians

More information

Flat Epithelial Atypia

Flat Epithelial Atypia Flat Epithelial Atypia Richard Owings, M.D. University of Arkansas for Medical Sciences Department of Pathology Flat epithelial atypia can be a difficult lesion May be a subtle diagnosis Lots of changes

More information

Proliferative Breast Disease: implications of core biopsy diagnosis. Proliferative Breast Disease

Proliferative Breast Disease: implications of core biopsy diagnosis. Proliferative Breast Disease Proliferative Breast Disease: implications of core biopsy diagnosis Jean F. Simpson, M.D. Breast Pathology Consultants, Inc. Nashville, TN Proliferative Breast Disease Must be interpreted in clinical and

More information

Slide seminar. Asist. Prof. Jože Pižem, MD, PhD Institute of Pathology Medical Faculty, University of Ljubljana

Slide seminar. Asist. Prof. Jože Pižem, MD, PhD Institute of Pathology Medical Faculty, University of Ljubljana Slide seminar Asist. Prof. Jože Pižem, MD, PhD Institute of Pathology Medical Faculty, University of Ljubljana Case 5 A 57-year-old man with a dermal/subcutaneous lesion on the scalp, which was interpreted

More information

Review and Updates of Immunohistochemistry in Selected Salivary Gland and Head and Neck Tumors

Review and Updates of Immunohistochemistry in Selected Salivary Gland and Head and Neck Tumors Review and Updates of Immunohistochemistry in Selected Salivary Gland and Head and Neck Tumors. Monophasic tumors : myoepithelioma, acinic cell carcinoma, and salivary duct carcinoma. Biphasic tumors includes

More information

1 NORMAL HISTOLOGY AND METAPLASIAS

1 NORMAL HISTOLOGY AND METAPLASIAS 1 NORMAL HISTOLOGY AND METAPLASIAS, MD Anatomy and Histology 1 Metaplasias 2 ANATOMY AND HISTOLOGY The female breast is composed of a branching duct system, which begins at the nipple with the major lactiferous

More information

Multiple Primary and Histology Site Specific Coding Rules BREAST. FLORIDA CANCER DATA SYSTEM MPH Breast Site Specific Coding Rules

Multiple Primary and Histology Site Specific Coding Rules BREAST. FLORIDA CANCER DATA SYSTEM MPH Breast Site Specific Coding Rules Multiple Primary and Histology Site Specific Coding Rules BREAST 1 Prerequisites 2 Completion of Multiple Primary and Histology General Coding Rules 3 There are many ways to view the Multiple l Primary/Histology

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION DOI:.38/ncb3399 a b c d FSP DAPI 5mm mm 5mm 5mm e Correspond to melanoma in-situ Figure a DCT FSP- f MITF mm mm MlanaA melanoma in-situ DCT 5mm FSP- mm mm mm mm mm g melanoma in-situ MITF MlanaA mm mm

More information

Utility of Adequate Core Biopsy Samples from Ultrasound Biopsies Needed for Today s Breast Pathology

Utility of Adequate Core Biopsy Samples from Ultrasound Biopsies Needed for Today s Breast Pathology Utility of Adequate Core Biopsy Samples from Ultrasound Biopsies Needed for Today s Breast Pathology Ugur Ozerdem, M.D. 1 Abstract Background: There is a paradigm shift in breast biopsy philosophy. In

More information

Invasive Papillary Breast Carcinoma

Invasive Papillary Breast Carcinoma 410 This is an Open Access article licensed under the terms of the Creative Commons Attribution- NonCommercial-NoDerivs 3.0 License (www.karger.com/oa-license), applicable to the online version of the

More information

Abnormally differentiating keratinocytes in the epidermis of systemic sclerosis patients show enhanced secretion of CCN2 and S100A9

Abnormally differentiating keratinocytes in the epidermis of systemic sclerosis patients show enhanced secretion of CCN2 and S100A9 Abnormally differentiating keratinocytes in the epidermis of systemic sclerosis patients show enhanced secretion of CCN2 and S1A9 Joanna Nikitorowicz-Buniak UCL Division of Medicine Systemic sclerosis

More information

6/3/2010. Outline of Talk. Lobular Breast Cancer: Definition of lobular differentiation. Common Problems in Diagnosing LCIS in Core Biopsies

6/3/2010. Outline of Talk. Lobular Breast Cancer: Definition of lobular differentiation. Common Problems in Diagnosing LCIS in Core Biopsies Outline of Talk Lobular Breast Cancer: Common Problems in Diagnosing LCIS in Core Biopsies Definition of lobular differentiation Variants of LCIS that: carry risk for unsampled invasive cancer mimic DCIS

More information

Rath, N., and Olson, M. (2016) Regulation of pancreatic cancer aggressiveness by stromal stiffening. Nature Medicine, 22(5), pp. 462-463. There may be differences between this version and the published

More information

supplementary information

supplementary information DOI: 10.1038/ncb2133 Figure S1 Actomyosin organisation in human squamous cell carcinoma. (a) Three examples of actomyosin organisation around the edges of squamous cell carcinoma biopsies are shown. Myosin

More information

Papillary Lesions of the Breast: WHO Update

Papillary Lesions of the Breast: WHO Update Papillary Lesions of the Breast: WHO Update Stuart J. Schnitt, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA, USA Papillary Lesions of the Breast

More information

Figure 1: Time course of gastric organoid formation. Figure 2: Schematics of standard organoid cultures in BME2 and at the air liquid interface (ALI).

Figure 1: Time course of gastric organoid formation. Figure 2: Schematics of standard organoid cultures in BME2 and at the air liquid interface (ALI). 1 Trevigen s Cultrex Basement Membrane Extract (BME) for in vitro Organoid/Spheroid Studies Hynda Kleinman, Ph.D., Jay George, Ph.D., and Gabriel Benton, Ph.D. Trevigen, Inc. Gaithersburg, MD There is

More information

Immunohistochemical classification of breast tumours

Immunohistochemical classification of breast tumours Immunohistochemical classification of breast tumours Workshop in Diagnostic Immunohistochemistry September 19 th - 21 th 2018 Anne-Vibeke Lænkholm Department of Surgical Pathology, Zealand University Hospital,

More information

Question 1 A. ER-, PR-, HER+ B. ER+, PR+, HER2- C. ER-, PR+, HER2- D. ER-, PR-, HER2- E. ER-, PR+, HER2+

Question 1 A. ER-, PR-, HER+ B. ER+, PR+, HER2- C. ER-, PR+, HER2- D. ER-, PR-, HER2- E. ER-, PR+, HER2+ Triple Negative Breast Cancer Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA Question 1 The tumor depicted on the next slide

More information

Tissue repair. (3&4 of 4)

Tissue repair. (3&4 of 4) Tissue repair (3&4 of 4) What will we discuss today: Regeneration in tissue repair Scar formation Cutaneous wound healing Pathologic aspects of repair Regeneration in tissue repair Labile tissues rapid

More information

Ductal Carcinoma in Situ. Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA

Ductal Carcinoma in Situ. Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA Ductal Carcinoma in Situ Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA Definition of DCIS WHO 2012 A neoplastic proliferation

More information

Contents 1 The Windows of Susceptibility to Breast Cancer 2 The So Called Pre-Neoplastic Lesions and Carcinoma In Situ

Contents 1 The Windows of Susceptibility to Breast Cancer 2 The So Called Pre-Neoplastic Lesions and Carcinoma In Situ Contents 1 The Windows of Susceptibility to Breast Cancer... 1 1.1 Introduction... 1 1.2 Risk Factor and Etiological Agents... 2 1.3 The Concept of the Windows of Susceptibility to Carcinogenesis... 5

More information

In situ lobular neoplasia of the breast with marked myoepithelial proliferation

In situ lobular neoplasia of the breast with marked myoepithelial proliferation In situ lobular neoplasia of the breast with marked myoepithelial proliferation Sami Shousha To cite this version: Sami Shousha. In situ lobular neoplasia of the breast with marked myoepithelial proliferation.

More information

Anti-idiotype and anti-immunoglobulin antibodies are promising biomarkers of early breast cancer

Anti-idiotype and anti-immunoglobulin antibodies are promising biomarkers of early breast cancer Anti-idiotype and anti-immunoglobulin antibodies are promising biomarkers of early breast cancer Marie-Claire Maroun, Lawrence Grossman, Rooshan Arshad, Leonard Lipovich, and Félix Fernández Madrid Wayne

More information

Minimizing Errors in Diagnostic Pathology

Minimizing Errors in Diagnostic Pathology Shahla Masood, M.D. Professor and Chair Department of Pathology and Laboratory Medicine University of Florida College of Medicine-Jacksonville Medical Director, Shands Jacksonville Breast Health Center

More information

Role of P-Cadherin as Myoepithelial Cell Marker in Differentiating Benign and Malignant Breast Lesions

Role of P-Cadherin as Myoepithelial Cell Marker in Differentiating Benign and Malignant Breast Lesions IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 7 Ver. IV (July. 2017), PP 09-17 www.iosrjournals.org Role of P-Cadherin as Myoepithelial Cell

More information

Pathology of Lobular & Ductal Preneoplasia. Syed A Hoda, MD Weill-Cornell, New York, NY

Pathology of Lobular & Ductal Preneoplasia. Syed A Hoda, MD Weill-Cornell, New York, NY Pathology of Lobular & Ductal Preneoplasia Syed A Hoda, MD Weill-Cornell, New York, NY Proliferative Epithelial Changes in Breast A wide range of proliferative epithelial changes occur in the breast There

More information

A Novel CTC-Detecting Technique Using TelomeScan and Its Clinical Applications

A Novel CTC-Detecting Technique Using TelomeScan and Its Clinical Applications A Novel CTC-Detecting Technique Using TelomeScan and Its Clinical Applications Yasuo Urata CEO and President Oncolys BioPharma Inc. February 16, 2013 Telomere Length is a Limiting Factor for Cell Replication

More information

Enterprise Interest None

Enterprise Interest None Enterprise Interest None What are triple negative breast cancers? A synopsis of their histological patterns Ian Ellis Molecular Medical Sciences, University of Nottingham Department of Histopathology,

More information

Epstein-Barr virus driven promoter hypermethylated genes in gastric cancer

Epstein-Barr virus driven promoter hypermethylated genes in gastric cancer RESEARCH FUND FOR THE CONTROL OF INFECTIOUS DISEASES Epstein-Barr virus driven promoter hypermethylated genes in gastric cancer J Yu *, KF To, QY Liang K e y M e s s a g e s 1. Somatostatin receptor 1

More information

Good afternoon everyone. First of all many thanks to Dr. Bonaventura and Dr. Arn for inviting

Good afternoon everyone. First of all many thanks to Dr. Bonaventura and Dr. Arn for inviting PATHOLOGY IN-SITU CARCINOMA, ROHIT BHARGAVA, MD 1 Good afternoon everyone. First of all many thanks to Dr. Bonaventura and Dr. Arn for inviting me here, it s great to be here and I m going to talk about

More information

The Angio-Ready Assay System

The Angio-Ready Assay System The Angio-Ready Assay System Kevin Grady, B.S. Product Line Business Manager, ATCC Cell Systems Charles Zou, Ph.D. Senior Scientist, ATCC Cell Systems About ATCC Founded in 1925, ATCC is a non-profit organization

More information

Layered-IHC (L-IHC): A novel and robust approach to multiplexed immunohistochemistry So many markers and so little tissue

Layered-IHC (L-IHC): A novel and robust approach to multiplexed immunohistochemistry So many markers and so little tissue Page 1 The need for multiplex detection of tissue biomarkers. There is a constant and growing demand for increased biomarker analysis in human tissue specimens. Analysis of tissue biomarkers is key to

More information

Molecular Characterization of Breast Cancer: The Clinical Significance

Molecular Characterization of Breast Cancer: The Clinical Significance Molecular Characterization of : The Clinical Significance Shahla Masood, M.D. Professor and Chair Department of Pathology and Laboratory Medicine University of Florida College of Medicine-Jacksonville

More information

Surgical Pathology Issues of Practical Importance

Surgical Pathology Issues of Practical Importance Surgical Pathology Issues of Practical Importance Anne Moore, MD Medical Oncology Syed Hoda, MD Surgical Pathology The pathologist is central to the team approach needed to manage the patient with breast

More information

Atypical proliferative lesions diagnosed on core biopsy - 6 year review

Atypical proliferative lesions diagnosed on core biopsy - 6 year review Atypical proliferative lesions diagnosed on core biopsy - 6 year review Dr Angela Harris, Dr Julie Weigner & Dr Ricardo Vilain NSW Health Pathology Pathology North, Hunter Anatomical Pathology & Cytology

More information

Breast pathology. 2nd Department of Pathology Semmelweis University

Breast pathology. 2nd Department of Pathology Semmelweis University Breast pathology 2nd Department of Pathology Semmelweis University Breast pathology - Summary - Benign lesions - Acute mastitis - Plasma cell mastitis / duct ectasia - Fat necrosis - Fibrocystic change/

More information

NCCN TRENDS DEMOGRAPHICS. Results: September 2012 DUCTAL CARCINOMA IN SITU (DCIS) Distribution of Respondent Types (n = 1,778) Page 1

NCCN TRENDS DEMOGRAPHICS. Results: September 2012 DUCTAL CARCINOMA IN SITU (DCIS) Distribution of Respondent Types (n = 1,778) Page 1 NCCN TRENDS Results: September 2012 NCCN Trends is an analytics tool from the National Comprehensive Cancer Network (NCCN ) that surveys how clinicians across the U.S. and around the globe are delivering

More information

Diseases of the breast (2 of 2) Breast cancer

Diseases of the breast (2 of 2) Breast cancer Diseases of the breast (2 of 2) Breast cancer Epidemiology & etiology The most common type of cancer & the 2 nd most common cause of cancer death in women 1 of 8 women in USA Affects 7% of women Peak at

More information

Recent advances in breast cancers

Recent advances in breast cancers Recent advances in breast cancers Breast cancer is a hetrogenous disease due to distinct genetic alterations. Similar morphological subtypes show variation in clinical behaviour especially in response

More information

Triple Negative Breast Cancer

Triple Negative Breast Cancer Triple Negative Breast Cancer Prof. Dr. Pornchai O-charoenrat Division of Head-Neck & Breast Surgery Department of Surgery Faculty of Medicine Siriraj Hospital Breast Cancer Classification Traditional

More information

Papillary Lesions of the Breast A Practical Approach to Diagnosis. (Arch Pathol Lab Med. 2016;140: ; doi: /arpa.

Papillary Lesions of the Breast A Practical Approach to Diagnosis. (Arch Pathol Lab Med. 2016;140: ; doi: /arpa. Papillary Lesions of the Breast A Practical Approach to Diagnosis (Arch Pathol Lab Med. 2016;140:1052 1059; doi: 10.5858/arpa.2016-0219-RA) Papillary lesions of the breast Span the spectrum of benign,

More information

04/10/2018 HIGH RISK BREAST LESIONS. Pathology Perspectives of High Risk Breast Lesions ELEVATED RISK OF BREAST CANCER HISTORICAL PERSPECTIVES

04/10/2018 HIGH RISK BREAST LESIONS. Pathology Perspectives of High Risk Breast Lesions ELEVATED RISK OF BREAST CANCER HISTORICAL PERSPECTIVES Pathology Perspectives of High Risk Breast Lesions Savitri Krishnamurthy MD Professor of Pathology Deputy Division Head Director of Clinical Trials, Research and Development The University of Texas MD

More information

Tissue Outline (chapter 4) Tissues group of cells that perform structural and roles. List the 4 types:

Tissue Outline (chapter 4) Tissues group of cells that perform structural and roles. List the 4 types: Tissue Outline (chapter 4) Tissues group of cells that perform structural and roles. List the 4 types: 1. 2. 3. 4. I. Epithelial Tissue covers all the surfaces, inside & out. Are the major tissues of,

More information

Notice of Faculty Disclosure

Notice of Faculty Disclosure California Society of Pathology Diagnostic Problems in Surgical Pathology December 2015 Case 2 Laura C. Collins, M.D. Associate Professor of Pathology Associate Director of Anatomic Pathology Beth Israel

More information

TEB. Id4 p63 DAPI Merge. Id4 CK8 DAPI Merge

TEB. Id4 p63 DAPI Merge. Id4 CK8 DAPI Merge a Duct TEB b Id4 p63 DAPI Merge Id4 CK8 DAPI Merge c d e Supplementary Figure 1. Identification of Id4-positive MECs and characterization of the Comma-D model. (a) IHC analysis of ID4 expression in the

More information

CPC 4 Breast Cancer. Rochelle Harwood, a 35 year old sales assistant, presents to her GP because she has noticed a painless lump in her left breast.

CPC 4 Breast Cancer. Rochelle Harwood, a 35 year old sales assistant, presents to her GP because she has noticed a painless lump in her left breast. CPC 4 Breast Cancer Rochelle Harwood, a 35 year old sales assistant, presents to her GP because she has noticed a painless lump in her left breast. 1. What are the most likely diagnoses of this lump? Fibroadenoma

More information

Maram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine

Maram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine Maram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine The most common non-skin malignancy of women 2 nd most common cause of cancer deaths in women, following

More information

Histological Type. Morphological and Molecular Typing of breast Cancer. Nottingham Tenovus Primary Breast Cancer Study. Survival (%) Ian Ellis

Histological Type. Morphological and Molecular Typing of breast Cancer. Nottingham Tenovus Primary Breast Cancer Study. Survival (%) Ian Ellis Morphological and Molecular Typing of breast Cancer Ian Ellis Molecular Medical Sciences, University of Nottingham Department of Histopathology, Nottingham University Hospitals NHS Trust Histological Type

More information

Supplementary Materials. for Garmy-Susini, et al, Integrin 4 1 signaling is required for lymphangiogenesis and tumor metastasis

Supplementary Materials. for Garmy-Susini, et al, Integrin 4 1 signaling is required for lymphangiogenesis and tumor metastasis Supplementary Materials for Garmy-Susini, et al, Integrin 4 1 signaling is required for lymphangiogenesis and tumor metastasis 1 Supplementary Figure Legends Supplementary Figure 1: Integrin expression

More information

Pancreatic intraepithelial

Pancreatic intraepithelial Pancreatic intraepithelial neoplasia (PanIN) Markéta Hermanová St. Anne s University Hospital Brno Faculty of Medicine, Masaryk University Precursor lesions of invasive pancreatic cancer Pancreatic intraepithelial

More information

Co-PI: Amy Trentham-Dietz, PhD

Co-PI: Amy Trentham-Dietz, PhD AD Award Number: W81XWH-11-1-0228 TITLE: Tumor Microenvironment and Progression to Invasion after a Diagnosis of Ductal Carcinoma In situ PRINCIPAL INVESTIGATOR: Patricia J. Keely, PhD Co-PI: Amy Trentham-Dietz,

More information

Basal phenotype: a powerful prognostic factor in small screen-detected invasive breast cancer with long-term follow-up ...

Basal phenotype: a powerful prognostic factor in small screen-detected invasive breast cancer with long-term follow-up ... 21 ORIGINAL ARTICLE Basal phenotype: a powerful prognostic factor in small screen-detected invasive breast cancer with long-term follow-up A J Evans, E A Rakha, S E Pinder, A R Green, C Paish and I O Ellis...

More information

Protocol for the Examination of Biopsy Specimens From Patients With Invasive Carcinoma of the Breast

Protocol for the Examination of Biopsy Specimens From Patients With Invasive Carcinoma of the Breast Protocol for the Examination of Specimens From Patients With Invasive Carcinoma of the Breast Version: BreastInvasive 1.0.0.0 Protocol Posting Date: February 2019 Accreditation Requirements The use of

More information

Breast Cancer. Dr. Andres Wiernik 2017

Breast Cancer. Dr. Andres Wiernik 2017 Breast Cancer Dr. Andres Wiernik 2017 Agenda: The Facts! (Epidemiology/Risk Factors) Biological Classification/Phenotypes of Breast Cancer Treatment approach Local Systemic Agenda: The Facts! (Epidemiology/Risk

More information

Breast cancer: IHC classification. Mogens Vyberg Professor of Clinical Pathology Director of NordiQC Aalborg University Hospital, Aalborg, Denmark

Breast cancer: IHC classification. Mogens Vyberg Professor of Clinical Pathology Director of NordiQC Aalborg University Hospital, Aalborg, Denmark Breast cancer: IHC classification Mogens Vyberg Professor of Clinical Pathology Director of NordiQC Aalborg University Hospital, Aalborg, Denmark http://upload.wikimedia.org/wikipedia/commons/1/1a/breast.svg

More information

Case Report Basaloid ductal carcinoma in situ arising in salivary gland metaplasia of the breast: a case report

Case Report Basaloid ductal carcinoma in situ arising in salivary gland metaplasia of the breast: a case report Int J Clin Exp Pathol 2014;7(9):6370-6374 www.ijcep.com /ISSN:1936-2625/IJCEP0001480 Case Report Basaloid ductal carcinoma in situ arising in salivary gland metaplasia of the breast: a case report Eun

More information

Impact of NM23-M1 "knock-out" on metastatic potential of hepatocellular carcinoma: a transgenic approach

Impact of NM23-M1 knock-out on metastatic potential of hepatocellular carcinoma: a transgenic approach Impact of NM23-M1 "knock-out" on metastatic potential of hepatocellular carcinoma: a transgenic approach NM23-M1 "knock- out" mice (without NDPK A) Experimental models of hepatocarcinogenesis Chemical

More information

Outline (1) Outline (2) Concepts in Prostate Pathology. Peculiarities of Prostate Cancer. Peculiarities of Prostate Cancer

Outline (1) Outline (2) Concepts in Prostate Pathology. Peculiarities of Prostate Cancer. Peculiarities of Prostate Cancer Concepts in Prostate Pathology Murali Varma Cardiff, UK wptmv@cf.ac.uk Sarajevo Nov 2013 Outline (1) Peculiarities of prostate cancer Peculiarities of prostate needle biopsy Needle bx vs. TURP Prostate

More information

# Best Practices for IHC Detection and Interpretation of ER, PR, and HER2 Protein Overexpression in Breast Cancer

# Best Practices for IHC Detection and Interpretation of ER, PR, and HER2 Protein Overexpression in Breast Cancer #1034 - Best Practices for IHC Detection and Interpretation of ER, PR, and HER2 Protein Overexpression in Breast Cancer Richard W. Cartun, MS, PhD Andrew Ricci, Jr, MD Department of Pathology Hartford

More information

Molecular mechanisms of Fibrosis: Targets of Therapy. John P Iredale University of Edinburgh, UK

Molecular mechanisms of Fibrosis: Targets of Therapy. John P Iredale University of Edinburgh, UK Molecular mechanisms of Fibrosis: Targets of Therapy John P Iredale University of Edinburgh, UK Take home messages: The wound healing MFBs of the liver and the hepatic macrophages are key players in progressive

More information

Mammary Epithelial Cell Subtype-Specific Analysis of Ras Pathway Activation

Mammary Epithelial Cell Subtype-Specific Analysis of Ras Pathway Activation The Pennsylvania State University The Graduate School Graduate Program in Cell and Molecular Biology Mammary Epithelial Cell Subtype-Specific Analysis of Ras Pathway Activation A Dissertation in Cell and

More information

Lesion Imaging Characteristics Mass, Favoring Benign Circumscribed Margins Intramammary Lymph Node

Lesion Imaging Characteristics Mass, Favoring Benign Circumscribed Margins Intramammary Lymph Node Lesion Imaging Characteristics Mass, Favoring Benign Circumscribed Margins Intramammary Lymph Node Oil Cyst Mass, Intermediate Concern Microlobulated Margins Obscured Margins Mass, Favoring Malignant Indistinct

More information

Present Role of Immunohistochemistry in the. Subtypes. Beppe Viale European Institute of Oncology University of Milan Milan-Italy

Present Role of Immunohistochemistry in the. Subtypes. Beppe Viale European Institute of Oncology University of Milan Milan-Italy Present Role of Immunohistochemistry in the Classification of Molecular Subtypes Beppe Viale European Institute of Oncology University of Milan Milan-Italy We know it is many diseases Breast cancer is

More information

Supplementary Figure 1 ITGB1 and ITGA11 increase with evidence for heterodimers following HSC activation. (a) Time course of rat HSC activation

Supplementary Figure 1 ITGB1 and ITGA11 increase with evidence for heterodimers following HSC activation. (a) Time course of rat HSC activation Supplementary Figure 1 ITGB1 and ITGA11 increase with evidence for heterodimers following HSC activation. (a) Time course of rat HSC activation indicated by the detection of -SMA and COL1 (log scale).

More information

Supplemental Information. The Therapeutic Effect. of Anti-HER2/neu Antibody Depends. on Both Innate and Adaptive Immunity CONTENTS:

Supplemental Information. The Therapeutic Effect. of Anti-HER2/neu Antibody Depends. on Both Innate and Adaptive Immunity CONTENTS: Cancer Cell, Volume 18 Supplemental Information The Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity SaeGwang Park, Zhujun Jiang, Eric D. Mortenson, Liufu Deng,

More information

nhibitors of angiogenesis can exhibit bell-shaped and U-shaped dose-response curves: relevance for cancer therapy Dr. Andrew R.

nhibitors of angiogenesis can exhibit bell-shaped and U-shaped dose-response curves: relevance for cancer therapy Dr. Andrew R. nhibitors of angiogenesis can exhibit bell-shaped and U-shaped dose-response curves: relevance for cancer therapy Dr. Andrew R. Reynolds Tumour Angiogenesis Group Breakthrough Breast Cancer Research Centre

More information

Neoplasia 18 lecture 8. Dr Heyam Awad MD, FRCPath

Neoplasia 18 lecture 8. Dr Heyam Awad MD, FRCPath Neoplasia 18 lecture 8 Dr Heyam Awad MD, FRCPath ILOS 1. understand the angiogenic switch in tumors and factors that stimulate and inhibit angiogenesis. 2. list the steps important for tumor metastasis

More information

Applications of IHC. Determination of the primary site in metastatic tumors of unknown origin

Applications of IHC. Determination of the primary site in metastatic tumors of unknown origin Applications of IHC Determination of the primary site in metastatic tumors of unknown origin Classification of tumors that appear 'undifferentiated' by standard light microscopy Precise classification

More information

Papillary Lesions of the Breast

Papillary Lesions of the Breast Papillary Lesions of the Breast Texas Society of Pathologists 2013 Laura C. Collins, M.D. Associate Professor of Pathology Associate Director, Division of Anatomic Pathology Beth Israel Deaconess Medical

More information

Benign Breast Disease and Breast Cancer Risk

Benign Breast Disease and Breast Cancer Risk Benign Breast Disease and Breast Cancer Risk Jean F. Simpson, M.D. Vanderbilt University Nashville, Tennessee December 1, 2011 Nashville Nashville Lebanon 1 Cedars of Lebanon State Park The American University

More information

CLINICAL-PATHOLOGICAL INDICATORS OF AN OPPORTUNISTIC BREAST CANCER SCREENING: A POPULATION-BASED STUDY

CLINICAL-PATHOLOGICAL INDICATORS OF AN OPPORTUNISTIC BREAST CANCER SCREENING: A POPULATION-BASED STUDY CLINICAL-PATHOLOGICAL INDICATORS OF AN OPPORTUNISTIC BREAST CANCER SCREENING: A POPULATION-BASED STUDY Bordoni A, Probst-Hensch NM, Mazzucchelli L, Spitale A Registro Tumori Canton Ticino Istituto Cantonale

More information

TITLE: Evaluation of DNA Methylation as a Target for Intraductal Therapy for Ductal Carcinoma in Situ of the Breast

TITLE: Evaluation of DNA Methylation as a Target for Intraductal Therapy for Ductal Carcinoma in Situ of the Breast AD AWARD NUMBER: DAMD17-02-1-0569 TITLE: Evaluation of DNA Methylation as a Target for Intraductal Therapy for Ductal Carcinoma in Situ of the Breast PRINCIPAL INVESTIGATOR: Kristin A. Skinner, M.D. CONTRACTING

More information

Resection Margins in Breast Conserving Surgery. Alberto Costa, MD Canton Ticino Breast Unit Lugano, Switzerland

Resection Margins in Breast Conserving Surgery. Alberto Costa, MD Canton Ticino Breast Unit Lugano, Switzerland Resection Margins in Breast Conserving Surgery Alberto Costa, MD Canton Ticino Breast Unit Lugano, Switzerland Breast Conserving Surgery 1 Probably one of the most important innovation in cancer surgery

More information

Rare Breast Tumours. 1. Breast Tumours. 1.1 General Results. 1.2 Incidence

Rare Breast Tumours. 1. Breast Tumours. 1.1 General Results. 1.2 Incidence Rare Breast Tumours 1. Breast Tumours 1.1 General Results Table 1. Epithelial Tumours of Breast: Incidence, Trends, Survival Flemish Region 2001-2010 Incidence Trend Survival Females EAPC Relative survival

More information

Supplementary Figure 1. Characterization of NMuMG-ErbB2 and NIC breast cancer cells expressing shrnas targeting LPP. NMuMG-ErbB2 cells (a) and NIC

Supplementary Figure 1. Characterization of NMuMG-ErbB2 and NIC breast cancer cells expressing shrnas targeting LPP. NMuMG-ErbB2 cells (a) and NIC Supplementary Figure 1. Characterization of NMuMG-ErbB2 and NIC breast cancer cells expressing shrnas targeting LPP. NMuMG-ErbB2 cells (a) and NIC cells (b) were engineered to stably express either a LucA-shRNA

More information

Nature Methods: doi: /nmeth Supplementary Figure 1

Nature Methods: doi: /nmeth Supplementary Figure 1 Supplementary Figure 1 Finite-element analysis of cell cluster dynamics in different cluster trap architectures. (a) Cluster-Chip (b) Filter (c) A structure identical to the Cluster-Chip except that one

More information

Cytyc Corporation - Case Presentation Archive - March 2002

Cytyc Corporation - Case Presentation Archive - March 2002 FirstCyte Ductal Lavage History: 68 Year Old Female Gail Index: Unknown Clinical History: Negative Mammogram in 1995 6 yrs. later presents with bloody nipple discharge Subsequent suspicious mammogram Suspicious

More information

USCAP 2012: Companion Meeting of the AAOOP. Update on lacrimal gland neoplasms: Molecular pathology of interest

USCAP 2012: Companion Meeting of the AAOOP. Update on lacrimal gland neoplasms: Molecular pathology of interest USCAP 2012: Companion Meeting of the AAOOP Vancouver BC, Canada, March 17, 2012 Update on lacrimal gland neoplasms: Molecular pathology of interest Valerie A. White MD, MHSc, FRCPC Department of Pathology

More information

A holistic approach to targeting breast cancer part II: Micronutrient synergy. Presented by: Dr. Neha Shanker DRRI

A holistic approach to targeting breast cancer part II: Micronutrient synergy. Presented by: Dr. Neha Shanker DRRI A holistic approach to targeting breast cancer part II: Micronutrient synergy Presented by: Dr. Neha Shanker DRRI Overview of the previous webinar In the last presentation we talked about: Increase in

More information

Negative Regulation of c-myc Oncogenic Activity Through the Tumor Suppressor PP2A-B56α

Negative Regulation of c-myc Oncogenic Activity Through the Tumor Suppressor PP2A-B56α Negative Regulation of c-myc Oncogenic Activity Through the Tumor Suppressor PP2A-B56α Mahnaz Janghorban, PhD Dr. Rosalie Sears lab 2/8/2015 Zanjan University Content 1. Background (keywords: c-myc, PP2A,

More information

DOUBLE STAINS. Toll-Free: Direct:

DOUBLE STAINS. Toll-Free: Direct: DOUBLE STAINS CD61 + CD71 DAB Brown: CD61 Alk. Phos. Red: CD71 Bone Marrow DAB Brown: Megakaryocytes Alk. Phos. Red: Erythroid Precursors 400x CD61 (2f2) 0.1 ml concentrate............. 161M-14 0.5 ml

More information

Have you been recently diagnosed with DCIS?

Have you been recently diagnosed with DCIS? Have you been recently diagnosed with DCIS? Jen D. A busy mother of two and active community volunteer. Jen D. A busy mother of 2 and active community volunteer. *DCIS = Ductal carcinoma in situ AnAn educational

More information

CHAPTER VII CONCLUDING REMARKS AND FUTURE DIRECTION. Androgen deprivation therapy is the most used treatment of de novo or recurrent

CHAPTER VII CONCLUDING REMARKS AND FUTURE DIRECTION. Androgen deprivation therapy is the most used treatment of de novo or recurrent CHAPTER VII CONCLUDING REMARKS AND FUTURE DIRECTION Stathmin in Prostate Cancer Development and Progression Androgen deprivation therapy is the most used treatment of de novo or recurrent metastatic PCa.

More information

Trevigen s Extracellular Matrix Proteins for Triculture of Breast Cancer Spheroids, Endothelial Tubules, and Human Mesenchymal Stem Cells

Trevigen s Extracellular Matrix Proteins for Triculture of Breast Cancer Spheroids, Endothelial Tubules, and Human Mesenchymal Stem Cells Trevigen s Extracellular Matrix Proteins for Triculture of Breast Cancer Spheroids, Endothelial Tubules, and Human Mesenchymal Stem Cells Gabriel Benton, Ph.D. and Jay George, Ph.D., Trevigen, Inc. Gaithersburg,

More information

National Mastectomy & Breast Reconstruction Audit Datasheet - Mastectomy +/- Immediate Reconstruction

National Mastectomy & Breast Reconstruction Audit Datasheet - Mastectomy +/- Immediate Reconstruction Patient Registration data Surname Forename NHS/Private Hospital Number Date of birth Postcode Ethnicity Patient-reported outcomes consent Has this patient consented to being sent outcome questionnaires?

More information

Update in Salivary Gland Pathology. Benjamin L. Witt University of Utah/ARUP Laboratories February 9, 2016

Update in Salivary Gland Pathology. Benjamin L. Witt University of Utah/ARUP Laboratories February 9, 2016 Update in Salivary Gland Pathology Benjamin L. Witt University of Utah/ARUP Laboratories February 9, 2016 Objectives Review the different appearances of a selection of salivary gland tumor types Establish

More information

M yoepithelial cells (MEC) are contractile elements

M yoepithelial cells (MEC) are contractile elements 625 ORIGINAL ARTICLE Immunostaining patterns of myoepithelial cells in breast lesions: a comparison of CD10 and smooth muscle myosin heavy chain A N Kalof, D Tam, B Beatty, K Cooper... See end of article

More information

Case study 1. Rie Horii, M.D., Ph.D. Division of Pathology Cancer Institute Hospital, Japanese Foundation for Cancer Research

Case study 1. Rie Horii, M.D., Ph.D. Division of Pathology Cancer Institute Hospital, Japanese Foundation for Cancer Research NCCN/JCCNB Seminar in Japan April 15, 2012 Case study 1 Rie Horii, M.D., Ph.D. Division of Pathology Cancer Institute Hospital, Japanese Foundation for Cancer Research Present illness: A 50y.o.premenopausal

More information